Phase III trials of olaparib for BRCA-mutated ovarian cancer initiated by @AstraZeneca | Dr. Ismail Hassan Ismail

Phase III trials of olaparib for BRCA-mutated ovarian cancer initiated by @AstraZeneca

Fri, 2014-02-28 07:03

https://twitter.com/Cortellis/status/375234309525102592